Back
Applied Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
APLT
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
72
APLT
Applied Therapeutics
Last Price:
8.00
Seasonality Move:
22.64%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pmApplied Therapeutics Price Quote
$8.00
+0.15 (+1.91%)
(Updated: September 19, 2024 at 6:55 PM ET)
Applied Therapeutics Key Stats
Buy
72
Applied Therapeutics (APLT)
is a Buy
Day range:
$6.46 - $8.41
52-week range:
$1.79 - $9.39
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
12.45%
Volume:
50.9M
Avg. volume:
2.8M
1-year change:
296.46%
Market cap:
$901.5M
Revenue:
$10M
EPS:
$-1.6
How Much Does Applied Therapeutics Make?
Data Unavailable
Is Applied Therapeutics Growing As A Company?
Data Unavailable
Applied Therapeutics Stock Price Performance
-
Did Applied Therapeutics Stock Go Up Last Month?
Applied Therapeutics share price went up by 34.19% last month -
Did APLT's Share Price Rise Over The Last Year?
APLT share price rose by 296.46% over the past 1 year
What Is Applied Therapeutics 52-Week High & Low?
-
What Is Applied Therapeutics’s 52-Week High Share Price?
Applied Therapeutics has traded as high as $9.39 over the past 52 weeks -
What Is Applied Therapeutics’s 52-Week Low Share Price?
Applied Therapeutics has traded as low as $1.79 over the past 52 weeks
Applied Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Applied Therapeutics?
-
How Much Debt Does Applied Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Applied Therapeutics Have?
Cash and short term investments quarterly total is $122.2M -
What Is Applied Therapeutics’s Book Value Per Share?
Book value per share is 0.63
Is Applied Therapeutics Cash Flow Positive?
-
What Is APLT Cash Flow From Operations?
Cash flow from operations (TTM) is -$73.2M -
What Is Applied Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $159.8M -
What Is Applied Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Applied Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
APLT return on invested capital is -735.65% -
What Is Applied Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -190.55% -
What Is APLT Return On Equity?
ROE is a measure of profitability and is -751.61%
Applied Therapeutics Earnings Date & Stock Price
-
What Is Applied Therapeutics's Stock Price Today?
A single share of APLT can be purchased today for 7.85 -
What Is Applied Therapeutics’s Stock Symbol?
Applied Therapeutics trades on the nasdaq under the ticker symbol: APLT -
When Is Applied Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Applied Therapeutics is scheduled on November 8, 2024 -
When Is APLT's next ex-dividend date?
Applied Therapeutics's next ex-dividend date is September 20, 2024 -
How To Buy Applied Therapeutics Stock?
You can buy Applied Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Applied Therapeutics Competitors
-
Who Are Applied Therapeutics's Competitors?
Below is a list of companies who compete with Applied Therapeutics or are related in some way:
Applied Therapeutics Dividend Yield
-
What Is APLT Dividend Yield?
Applied Therapeutics’s dividend yield currently is 0% -
What Is Applied Therapeutics’s Payout Ratio?
Applied Therapeutics’s payout ratio is 0% -
When Did Applied Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Applied Therapeutics’s Dividend Per Share?
Applied Therapeutics pays a dividend of $0.00 per share
Applied Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 110.97% |
Revenue: | 0% | -94.24% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 12.50 |
Upside from Last Price: | 59.24% |